Fast Optical Sectioning of Developing Organisms and Tissue Microstructures

ZEISS Lattice SIM 3 exploits the full potential of the SIM Apotome technology.

Government apoints new experts to medicine and health council

Johanna Fälting, Head of Research at BioArctic, and physician Markus Lingman have been appointed as new members of the Swedish Research Council’s Subject Counci...

ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics

Live imaging with uniform super-resolution in all spatial dimensions.

Även Sanofi pausar brittiska investeringar

Sanofi går i flera andra läkemedelsjättars fotspår och fryser alla investeringsbeslut om forskning och utveckling i Storbritannien.

Stor kongress om framtidsutsikter igång i Lund

Vad sker i framtiden inom svensk och dansk life science? Det diskuteras i dag vid eventet The Future of Swedish and Danish Life Science i Lund.

Partial court victory for entrepreneur who lost his company

Swedish life science entrepreneur Mikael Kubista has won the first round against a law firm that he, along with other co-owners, sued for negligent advice in co...

Ålder som hinder – Så hittar du nya jobbmöjligheter efter 55

Trots lång erfarenhet har många svårt att ta sig vidare i karriären efter 55. Karriärcoachen Tina Persson råder att lyfta fram överförbara kunskaper och att vår...

”The importance of stratification in a statistician’s August kitchen”

Ingrid Lönnstedt writes about an experiment of her own at home and about what lessons can be learned from it, in a science column.

Stockholm and Uppsala jointly form a life science cluster

Stockholm and Uppsala are strengthening cooperation in medical research and biotech.

Recipharm i samarbete om ny ALS-behandling

Recipharm ska samarbeta med israeliska Neurosense Therapeutics om att ta en ny behandling för den neurodegenerativa sjukdomen ALS vidare till fas III-studier.

High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

ZEISS Axioscan 7.

Sahlgrenska Science Park

Efficient use of blood plasma

Blood plasma is an indispensable resource in the production of life-saving medicines. It is in high demand on global markets. To make more efficient use of this...

He takes over the chairmanship of Karolinska Development

Ben Toogood is appointed as the new chairman of Karolinska Developments.

Drug development booms in Medicon Valley

When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on commission for pharmaceutical compani...

ZEN core now available for all ZEISS scanning electron microscopes

Introducing intuitive, streamlined SEM control over imaging, analytics, and multi-modal workflows.

A modular system for precise and automated cell dispensing

How the benefits of laboratory automation can be combined with gentle cell handling.

AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence

AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.

Quality solutions for medical device R&D applications

From R&D to the quality assurance of series production in medical device manufacturing.

Investeraren: ”De stora folksjukdomarna är heta igen”

Hon har tidigare utsetts till Årets investerare och ska nu moderera kongressen The Future of Swedish & Danish Life Science. Vi tar tempen på branschen med Nina ...

De får medicinpriset för upptäckt av immuntolerans

Året Nobelpris i fysiologi eller medicin tilldelas Mary Brunkow, Fred Ramsdell och Shimon Sakaguchi.

Nobelpristagare spår första AI-läkemedlet redan nästa år

De första AI-utvecklade läkemedlen kan börja prövas redan mot slutet av året. Det säger Demis Hassabis, Googles chef för Deepmind och medgrundare till Isomorphic Labs.

Johan Pehrson takes over the responsibility for research policy in Sweden

The Liberals' party leader Johan Pehrson takes over the assignment as Minister for Education. This was announced by Prime Minister Ulf Kristersson (M) on Tuesday last week.

Han är ny vd för Atrogi – ska ta obesitaskandidat till nästa fas

Det svenska bioteknikbolaget Atrogi, som utvecklar en oral kandidat mot obesitas, har utsett Paul Little till ny vd med omedelbar verkan.